IVA requests patients who have prescribed Ranitidine and Zantac® to return it to their pharmacist

Dit item is gearchiveerd op 22-11-2019.

ORANJESTAD: The Public Health Inspectorate has received a notification to recall the following medicines from the market.

  • Ranitidine (sold under the name Ranitidine);
  • and Zantac®.

These drugs are produced by the following pharmaceutical companies:

  • Accord Healthcare B.V;
  • Apotex Nederland B.V .;
  • Aurobindo Pharma B.V .;
  • GSK, Mylan B.V .;
  • Omega Pharma Nederland B.V .;
  • Sandoz B.V.;
  • Teva Nederland B.V.

The reason for this recall is that Ranitidine may contain traces of N-Nitrosodimethylamine (NDMA). However. the risk of getting cancer through the use of Ranitidine infected with NDMA has not yet been established.

Ad Recall Ranitidine and Zantac Heartburn inhibitors are prescribed to people with stomach complaints, such as heartburn and pain. People who have received Ranitidine and /or Zantac® on prescription from these companies are requested not to use the product and to return it to their pharmacist. They must also visit their family doctor to exchange this medicine for another medicine.

The Inspector of Medicine, Roslyn Angela (pharmacist) urges all patients who received Ranitidine on prescription to immediately stop taking this medicine and return it to their pharmacist. The Inspector also requests all patients to contact their pharmacist or doctor if they have questions or are concerned.

The Public Health Inspection Aruba will keep you informed of the latest developments in this case.

Below is a list of the medicines that have been recalled from the market:

We work together on an informative, accessible and user-friendly Government Portal for Aruba.
Report something? Click here

Page options